Cargando…

Pharmacological Characterization of µ-Opioid Receptor Agonists with Biased G Protein or β-Arrestin Signaling, and Computational Study of Conformational Changes during Receptor Activation

In recent years, G protein vs. β-arrestin biased agonism at opioid receptors has been proposed as an opportunity to produce antinociception with reduced adverse effects. However, at present this approach is highly debated, a reason why more information about biased ligands is required. While the pra...

Descripción completa

Detalles Bibliográficos
Autores principales:	Piekielna-Ciesielska, Justyna, Artali, Roberto, Azzam, Ammar A. H., Lambert, David G., Kluczyk, Alicja, Gentilucci, Luca, Janecka, Anna
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2020
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7792944/ https://www.ncbi.nlm.nih.gov/pubmed/33375124 http://dx.doi.org/10.3390/molecules26010013

Ejemplares similares

Synthesis, Biological Activity and Molecular Docking of Chimeric Peptides Targeting Opioid and NOP Receptors
por: Wtorek, Karol, et al.
Publicado: (2022)

Synthesis and Pharmacological Evaluation of Hybrids Targeting Opioid and Neurokinin Receptors
por: Wtorek, Karol, et al.
Publicado: (2019)

Design, Synthesis and Functional Analysis of Cyclic Opioid Peptides with Dmt-Tic Pharmacophore
por: Sarkar, Arijit, et al.
Publicado: (2020)

Characterization of methadone as a β-arrestin-biased μ-opioid receptor agonist
por: Doi, Seira, et al.
Publicado: (2016)

Harnessing the Anti-Nociceptive Potential of NK2 and NK3 Ligands in the Design of New Multifunctional μ/δ-Opioid Agonist–Neurokinin Antagonist Peptidomimetics
por: Gadais, Charlène, et al.
Publicado: (2021)

Synthesis, Pharmacological Evaluation, and Computational Studies of Cyclic Opioid Peptidomimetics Containing β(3)-Lysine
por: Wtorek, Karol, et al.
Publicado: (2021)

Functional selectivity of EM-2 analogs at the mu-opioid receptor
por: Piekielna-Ciesielska, Justyna, et al.
Publicado: (2023)

Synthesis and Evaluation of Novel Biased μ-Opioid-Receptor (μOR) Agonists
por: Ma, Mengjun, et al.
Publicado: (2019)

Usefulness for the combination of G protein- and β-arrestin-biased ligands of μ-opioid receptors: Prevention of antinociceptive tolerance
por: Mori, Tomohisa, et al.
Publicado: (2017)

Desmetramadol Is Identified as a G-Protein Biased µ Opioid Receptor Agonist
por: Zebala, John A., et al.
Publicado: (2020)

Structure‐Based Evolution of G Protein‐Biased μ‐Opioid Receptor Agonists
por: Wang, Haoqing, et al.
Publicado: (2022)

β-Arrestin–Biased Angiotensin II Receptor Agonists for COVID-19
por: Manglik, Aashish, et al.
Publicado: (2020)

Influence of G protein-biased agonists of μ-opioid receptor on addiction-related behaviors
por: Kudla, Lucja, et al.
Publicado: (2021)

Discovery of SHR9352: A Highly Potent G Protein-Biased μ-Opioid Receptor Agonist
por: Li, Xin, et al.
Publicado: (2017)

Subacute toxicity evaluations of LPM3480392 in rats, a full µ-opioid receptor biased agonist
por: Ye, Liang, et al.
Publicado: (2023)

Exploration of beta-arrestin isoform signaling pathways in delta opioid receptor agonist-induced convulsions
por: Blaine, Arryn T., et al.
Publicado: (2022)

Structural Determinants for the Binding of Morphinan Agonists to the μ-Opioid Receptor
por: Cong, Xiaojing, et al.
Publicado: (2015)

μ-opioid receptor agonists and psychedelics: pharmacological opportunities and challenges
por: Salinsky, Leah M., et al.
Publicado: (2023)

Dezocine is a Biased Ligand without Significant Beta-Arrestin Activation of the mu Opioid Receptor
por: Grothusen, John, et al.
Publicado: (2022)

Comparison of an Addictive Potential of μ-Opioid Receptor Agonists with G Protein Bias: Behavioral and Molecular Modeling Studies
por: Kudla, Lucja, et al.
Publicado: (2021)

Delineating the Ligand–Receptor Interactions That Lead to Biased Signaling at the μ-Opioid Receptor
por: Kelly, Brendan, et al.
Publicado: (2021)

Design of κ-Opioid Receptor Agonists for the Development of Potential Treatments of Pain with Reduced Side Effects
por: Santino, Federica, et al.
Publicado: (2023)

Agonist dependency of the second phase access of β-arrestin 2 to the heteromeric µ-V1b receptor
por: Ngamlertwong, Nuttawadee, et al.
Publicado: (2021)

Structural heterogeneity of the μ-opioid receptor’s conformational ensemble in the apo state
por: Sena, Diniz M., et al.
Publicado: (2017)

Conformational dynamics of the μ-opioid receptor determine ligand intrinsic efficacy
por: Zhao, Jiawei, et al.
Publicado: (2023)

Ang-(1-7) is an endogenous β-arrestin-biased agonist of the AT(1) receptor with protective action in cardiac hypertrophy
por: Teixeira, Larissa B., et al.
Publicado: (2017)

Discovery of β-Arrestin-Biased 25CN-NBOH-Derived 5-HT(2A) Receptor Agonists
por: Poulie, Christian B. M., et al.
Publicado: (2022)

Conformational signatures in β-arrestin2 reveal natural biased agonism at a G-protein-coupled receptor
por: Reyes-Alcaraz, Arfaxad, et al.
Publicado: (2018)

Conformational specificity of opioid receptors is determined by subcellular location irrespective of agonist
por: Crilly, Stephanie E, et al.
Publicado: (2021)

Antinociceptive potency of a fluorinated cyclopeptide Dmt-c[D-Lys-Phe-p-CF(3)-Phe-Asp]NH(2)
por: Piekielna-Ciesielska, Justyna, et al.
Publicado: (2018)

The atypical antidepressant and neurorestorative agent tianeptine is a μ-opioid receptor agonist
por: Gassaway, M M, et al.
Publicado: (2014)

Atomic-Level Characterization of the Methadone-Stabilized Active Conformation of µ-Opioid Receptor
por: Kapoor, Abhijeet, et al.
Publicado: (2020)

Genetic and biased agonist-mediated reductions in β-arrestin recruitment prolong cAMP signaling at glucagon family receptors
por: Jones, Ben, et al.
Publicado: (2020)

Stabilization of pre-existing neurotensin receptor conformational states by β-arrestin-1 and the biased allosteric modulator ML314
por: Bumbak, Fabian, et al.
Publicado: (2023)

The β-blocker Nebivolol Is a GRK/β-arrestin Biased Agonist
por: Erickson, Catherine E., et al.
Publicado: (2013)

N-Phenethyl Substitution in 14-Methoxy-N-methylmorphinan-6-ones Turns Selective µ Opioid Receptor Ligands into Dual µ/δ Opioid Receptor Agonists
por: Dumitrascuta, Maria, et al.
Publicado: (2020)

A Facile Synthesis for Novel Loperamide Analogs as Potential μ Opioid Receptor Agonists
por: Bao, Xiaofeng, et al.
Publicado: (2012)

Computational Drug Design of Novel Agonists of the μ -Opioid Receptor to Inhibit Pain Signaling
por: Daoud, Nancy, et al.
Publicado: (2023)

Identification of a Conformational Equilibrium That Determines the Efficacy and Functional Selectivity of the μ-Opioid Receptor
por: Okude, Junya, et al.
Publicado: (2015)

Comparative analyses of downstream signal transduction targets modulated after activation of the AT(1) receptor by two β-arrestin-biased agonists
por: Santos, Geisa A., et al.
Publicado: (2015)

Cannot write session to /tmp/vufind_sessions/sess_rhrp8bjp6lc6sibpueeai6vuse